Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding | 1.15% | $136.61M | $380.48B | 47.00% | 81 Outperform | |
| AstraZeneca | 1.05% | $124.81M | £218.59B | 33.88% | 76 Outperform | |
| Roche Holding AG | 1.03% | $122.73M | CHF250.94B | 38.47% | 73 Outperform | |
| Nestlé SA | 0.97% | $115.04M | CHF202.01B | 15.24% | 71 Outperform | |
| Shell (UK) | 0.97% | $114.80M | £158.51B | 8.98% | 77 Outperform | |
| HSBC Holdings | 0.93% | $110.29M | £180.44B | 43.54% | 79 Outperform | |
| Royal Bank Of Canada | 0.86% | $102.33M | $214.19B | 22.61% | 75 Outperform | |
| SAP SE | 0.78% | $92.62M | €239.08B | -8.13% | 66 Neutral | |
| Sony | 0.78% | $92.51M | ¥26.81T | 43.55% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 0.71% | $83.89M | €307.85B | 5.25% | 78 Outperform |